Skip to main navigation Skip to search Skip to main content

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis (Nature Cardiovascular Research, (2023), 2, 6, (550-571), 10.1038/s44161-023-00278-y)

  • Letizia Amadori
  • , Claudia Calcagno
  • , Dawn M. Fernandez
  • , Simon Koplev
  • , Nicolas Fernandez
  • , Ravneet Kaur
  • , Pauline Mury
  • , Nayaab S. Khan
  • , Swathy Sajja
  • , Roza Shamailova
  • , Yannick Cyr
  • , Minji Jeon
  • , Christopher A. Hill
  • , Peik Sean Chong
  • , Sonum Naidu
  • , Ken Sakurai
  • , Adam Ali Ghotbi
  • , Raphael Soler
  • , Natalia Eberhardt
  • , Adeeb Rahman
  • Peter Faries, Kathryn J. Moore, Zahi A. Fayad, Avi Ma’ayan, Chiara Giannarelli

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

Correction to: Nature Cardiovascular Research. Published online 8 June 2023. In the version of this article initially published, a protein (pMAPKAPK2) was misspelled in Fig. 1 and Extended Data Fig. 7; a colored box for “AKT” was missing from the second column of regulators in Fig. 5a; Extended Data Fig. 2f was missing a header above the color key; and typographical errors (extraneous citations to refs. 1, 3 and 5) were present in the “Analysis of RNA-seq data from saracatinib-treated tissue” section of Methods. In addition, the Reporting Summary and the legends for Supplementary Figs. 5 and 8 were outdated versions. The errors have been corrected in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)793
Number of pages1
JournalNature Cardiovascular Research
Volume2
Issue number8
DOIs
StatePublished - Aug 2023

Fingerprint

Dive into the research topics of 'Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis (Nature Cardiovascular Research, (2023), 2, 6, (550-571), 10.1038/s44161-023-00278-y)'. Together they form a unique fingerprint.

Cite this